tirzepatide redness at injection site 18 Possible Side Effects of (Mounjaro, Zepbound) Tirzepatide injection site reaction treatment:

Interestingly, the benefit of liraglutide for tau phosphorylation in diabetic mice cannot be replicated by insulin treatment, suggesting that the unique neuroprotective effects of GLP-1RAs are medicated by pathways other than insulin signaling pathways [62]

In a 2022 study of tirzepatide participants who took a weekly 15 mg dose lost an average of 20.9% of their body weight over 72 weeks, compared with 3.1% in the placebo group

Diabetes, 65(4), 1023-1031

Two new drugs are showing promise for cardiometabolic benefits beyond weight loss: Orforglipron: GLP-1 medication given as a daily pill instead of a weekly injection